betamethasone dipropionate
Selected indexed studies
- Betamethasone dipropionate spray 0.05% alleviates troublesome symptoms of plaque psoriasis. (Cutis, 2020) [PMID:32186532]
- Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data. (Expert Rev Clin Immunol, 2020) [PMID:32476507]
- Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review. (Indian J Dermatol Venereol Leprol, 2016) [PMID:26924402]
_Worker-drafted node — pending editorial review._
Connections
betamethasone dipropionate is a side effect of
Sources
- Betamethasone dipropionate spray 0.05% alleviates troublesome symptoms of plaque psoriasis. (2020) pubmed
- Topical calcipotriol/betamethasone dipropionate for psoriasis vulgaris: A systematic review. (2016) pubmed
- Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp. (2011) pubmed
- Calcipotriol/betamethasone dipropionate formulations for psoriasis: an overview of the options and efficacy data. (2020) pubmed
- Calcipotriol/Betamethasone Dipropionate Foam: A Review in Plaque Psoriasis. (2016) pubmed
- Review of Calcipotriene and Betamethasone Dipropionate Cream in the Treatment of Psoriasis. (2023) pubmed
- Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: a review of real-world evidence (RWE). (2021) pubmed
- Calcipotriene betamethasone dipropionate aerosol foam in the treatment of plaque psoriasis: a review of the literature. (2017) pubmed
- Clotrimazole-Betamethasone Dipropionate Prescribing for Nonfungal Skin Conditions. (2024) pubmed
- Betamethasone Dipropionate Nanocrystals: Investigation, Feasibility and In Vitro Evaluation. (2022) pubmed